Trial intelligence / Profile preview

Influenza vaccination in patients with Myasthenia Gravis

2016-003138-26Phase 4Active

Sponsor
Leiden University Medical Center
Start
Aug 2016
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

Phase 4, single-arm trial of influenza vaccine in myasthenia gravis (MG) and influenza, sponsored by Leiden University Medical Center. Primary endpoint: Change in influenza-specific serum IgG titer. Started Aug 2016; status: active.

02

Drugs

influenza vaccine
03

Conditions

myasthenia gravis (MG)influenza

Beyond the preview

Go deeper on 2016-003138-26.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2016-003138-26.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call